alexa Ovarian Cancer Screening And The Clinical Surveillance Of Ovarian Abnormalities | 71150
ISSN: 2161-0932

Gynecology & Obstetrics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Congress on Contemporary Issues in Women Cancers & Gynecologic Oncology

Edward J Pavlik
The University of Kentucky, USA
Keynote: Gynecol Obstet (Sunnyvale)
DOI: 10.4172/2161-0932-C1-017
Abstract
Women that are positive for an ovarian abnormality in a clinical setting can have either a malignancy or a benign tumor with probability favoring the benign alternative. Discovering a malignancy as early as possible will lead to extended survival. Surgery on benign abnormalities results in unnecessary procedures introducing cost burdens.Surveillance using serial ultrasonography can be used to discover if changes in the ovarian abnormality will occur that favor either a malignant or benign interpretation. Several ovarian cancer screening trials have had experiences with changes in sub-clinical ovarian abnormalities in normal women that can define growth, stability or resolution and the time frame over which changes occur. The present report examines information from screening trials, and relates it to ovarian cancer ontology, presenting arguments related to the benefits of surveillance. Intricacies of ovarian cancer screening are considered as ten considerations: 1. Deciding on the number to be screened, 2. Anticipating reductions due to death, 3. Deciding the duration and frequency of screening, 4. Deciding on the follow-up period, 5. Deciding on time to surgery, 6. Deciding on how screening cases are treated and by whom, 7. Deciding on how to treat data, 8. Deciding on how to assign disease specific death, 9. Deciding how to avoid participants with late stage disease, 10. Deciding whether the screening tool or a screening process is being tested. The considerations presented provide explanations of effects that have an important bearing on interpreting ovarian screening outcomes and the surveillance of ovarian abnormalities in clinical practice.
Biography

Edward J Pavlik is a Graduate of the University of Denver, and received his PhD from the University of Tennessee, Knoxville. He received a NCI Public Health Service Fellowship at the University of Illinois, Champaign-Urbana, Illinois and was a Visiting Assistant Professor, Department of Physiology and Biophysics at the University of Illinois, Champaign-Urbana. He is an active Lecturer and a Member of the Graduate College, serving on PhD dissertation committees with research focused on ovarian cancer screening and factors that affect screening accuracy and performance. He has authored over 100 peer reviewed publications.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]icsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7